The proposed bill, known as the Vulnerable Child Compassion and Protection Act, seeks to prohibit healthcare providers from performing medical procedures or prescribing medications intended to alter a minor child's gender or delay puberty. Specifically, it prohibits practices such as prescribing puberty blockers, administering supraphysiologic doses of testosterone to females, and administering supraphysiologic doses of estrogen to males, unless the procedure is necessary to treat a medically verifiable disorder of sex development. A violation of these prohibitions would be classified as a class B felony.

The bill introduces new legal language by adding a chapter (332-N) to the existing law, which defines key terms such as "minor," "person," and "sex." It also outlines the specific prohibitions for healthcare providers and clarifies that the restrictions do not apply to certain medical treatments for individuals with disorders of sex development. The act is set to take effect on January 1, 2026, and its implementation may have indeterminable fiscal impacts on state and local governments due to potential changes in judicial and correctional costs associated with the new penalties.